Health

Norgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand

NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and US WorldMeds (USWM), a Kentucky-based specialty pharmaceutical company, today announced an exclusive licensing agreement by which Norgine will register and commercialise difluoromethylornithine, DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand. DFMO is a repurposed molecule investigated for use as an extended […]

thaipr.net

23 ก.ค. 64

Texas Cardiac Arrhythmia Institute leader participates in clinical trial for world’s first artificial intelligence technology for complex cardiac arrhythmia procedures

The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center recently led a clinical study to evaluate the world’s first data-driven artificial intelligence (AI) platform for cardiac electrophysiology (EP) procedures. Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI, conducted the first-in-human trial in Europe. The NeuTrace EP Platform…

thaipr.net

23 ก.ค. 64

iHerb Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

iHerb Holdings, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been […]

thaipr.net

22 ก.ค. 64

Intas Enters into an Exclusive License Agreement with Meiji and Dong-A ST to commercialize DMB-3115 (Proposed Biosimilar to Ustekinumab)

Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreement Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreement with Meiji and Dong-A Socio Holdings (a parent company of Dong-A […]

thaipr.net

22 ก.ค. 64

Menarini Asia-Pacific strengthens Men’s Health portfolio in China with acquisition of Cialis(R) (Tadalafil) from Lilly

Acquisition of Cialis® in the People’s Republic of China to bolster Menarini’s Men’s Health portfolio and drive multichannel coverage This is a significant milestone for Menarini Asia operations as it commemorates its 10th anniversary of being established in 13 major healthcare markets in Asia-Pacific A. Menarini Asia-Pacific Holdings Pte. Ltd., part of the Menarini Group, the […]

thaipr.net

22 ก.ค. 64

RedHill Biopharma Announces Last Patient Out for Phase 2/3 COVID-19 Study of Oral Opaganib

Patient follow-up completed for the 475-patient global Phase 2/3 study of oral opaganib for severe COVID-19 Top-line results expected in the coming weeks Opaganib, a novel, dual antiviral and anti-inflammatory investigational COVID-19 pill, demonstrated potent inhibition of Beta and Gamma variants and is expected to be effective against emerging variants, including Delta and Delta Plus RedHill […]

thaipr.net

21 ก.ค. 64
1 … 103 104 105 106 107 … 127

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.